M2946

Mosapride citrate salt

≥98% (HPLC), solid, 5-HT₄ receptor agonist

• Sinónimos: 4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl ]-2-morpholinyl]methyl]benzamide citrate
• Fórmula empírica (notación de Hill): C₂₁H₂₅ClFN₃O₃ · C₆H₈O₇ · 2H₂O
• Número de CAS: 636582-62-2
• Peso molecular: 650.05
• MDL number: MFCD00874415
• UNSPSC Code: 12352200
• PubChem Substance ID: 329817957
• NACRES: NA.77

Propiedades

• Nombre del producto: Mosapride citrate salt,
• assay: ≥98% (HPLC)
• Quality Level: 100
• form: solid
• solubility: DMSO: ≥5 mg/mL
• originator: Takeda
• storage temp.: 2-8°C
• SMILES string: O.O.OC(=O)CC(O)(CC(O)=O)C(O)=O.CCOc1cc(N)c(Cl)cc1C(=O)NCC2CN(CCO2)Cc3ccc(F)cc3
• InChI: 1S/C21H25ClFN3O3.C6H8O7.2H2O/c1-2-28-20-10-19(24)18(22)9-17(20)21(27)25-11-16-13-26(7-8-29-16)12-14-3-5-15(23)6-4-14;7-3(8)1-6(13,5(11)12)2-4(9)10;;/h3-6,9-10,16H,2,7-8,11-13,24H2,1H3,(H,25,27);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);2*1H2
• InChI key: KVKIQHMTGSGTFO-UHFFFAOYSA-N

Descripción

Biochem/physiol Actions

Mosapride is found effective against chronic gastritis, functional dyspepsia and gastro-oesophageal reflux disease. It is useful in treating many other symptoms associated with gastrointestinal disorders. Mosapride is known to improve digestive motility.

5-HT₄ receptor agonist and 5-HT₃ receptor antagonist

Features and Benefits

This compound was developed by Takeda. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Información de seguridad

• pictograms: GHS05
• signalword: Danger
• hcodes: H318
• pcodes: P280 - P305 + P351 + P338
• Hazard Classifications: Eye Dam. 1
• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: dust mask type N95 (US), Eyeshields, Gloves